Events

Biocom’s Annual Global Life Science Partnering & Investor Conference: 2023

Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 28^th – March 2^nd, 2023 in San Diego, California.

World Congress on Pain 2022

Algomedix participated in IASP 2022 World Congress on Pain International meeting, which was held September 19^th – 23^rd , Metro Toronto Convention Center, Toronto, Canada.

Biocom’s Annual Global Life Science Partnering Conference : 2022

Algomedix will be attending and holding partnering meetings at Biocom’s Annual Global Life Science Partnering Conference, February 22^nd -24^th, 2022 in San Diego, California.

Bio-Japan: Asia’s Premier Partnering Event for the Global Biotechnology Industry 2021

Algomedix has been selected to participate in the Bio-Japan 2021 meeting: Asia’s Premier Partnering Event for the Global Biotechnology Industry, October 13th – 15th, 2021, at the Pacifico, Yokohama, Japan. Algomedix is attending as part of the Biocom California Pavilion.

Algomedix will be available for partnering discussions from October 15^th – November 15^th, 2021 via online meetings. Please visit the following link for more information.

https://jcd-expo.jp/en/digital-event-Biocom.html

BioKorea: 2021

Algomedix participated in Bio Korea 2021 International meeting, which was being held from June 9^th – 11^th; Onsite, and June 6^th  – 21^st; Online 2021 at CoEx Exhibition Center, Seoul, South Korea.

Bio Asia – Taiwan: 2020

Algomedix has been selected to participate in the meeting: Bio Asia – Taiwan 2020, which is being held from July 22^nd – 26^th,  2020 at Taipei Nangang Exhibition Hall, Taipei, Taiwan. Please meet us at Booth No. R913 at the Washington State Trade and Investment Office.

Experimental Biology Conference: 2020

Algomedix will be presenting scientific results at the Experimental Biology, 2020, conference which is being held from April 4^th – 7^th, 2020 in San Diego, California.

Algomedix will be present on ALGX-XC20, a Novel Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonist Attenuates Joint Pain and Articular Cartilage Damage in an Osteoarthritis Rat Model on April 6^th, 2020 from 4:45 PM – 6:00 PM, at Notable Platform Presentations in Drug Discovery and Development, San Diego Convention Center.

In addition, Algomedix will be presenting on Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS) on April 7^th, 2020 at the San Diego Convention Center.

Biocom’s 10th Annual Global Life Science Partnering Conference : 2020

Algomedix will be attending and holding partnering meetings at Biocom’s 10^th Annual Global Life Science Partnering Conference, February 25^th-27^th, 2020 in La Jolla, California.

Kyoto University Life Science Showcase: 2020

Algomedix will be participating in the Kyoto University Life Science meeting on February 28^th, 2020 in La Jolla, California at the Sanford Consortium for Regenernative Medicine.

Bio-Japan: Asia’s Premier Partnering Event for the Global Biotechnology Industry 2019

Algomedix has been selected to participate in the Bio-Japan 2019 meeting: Asia’s Premier Partnering Event for the Global Biotechnology Industry 2019, October 9^th – 12^th, 2019, Pacifico, Yokohama, Japan. Algomedix will join the California Biocom delegation at the meeting.